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and James A. Seddon1,4*Abstract
Background: The relative fitness of organisms causing drug-susceptible (DS) and multidrug-resistant (MDR) tuberculosis
(TB) is unclear. We compared the risk of TB infection and TB disease in young child household contacts of adults with
confirmed DS-TB and MDR-TB.
Methods: In this cross-sectional analysis we included data from two community-based contact cohort investigation
studies conducted in parallel in Cape Town, South Africa. Children <5 years of age with household exposure to an
infectious TB case were included between August 2008 to June 2011. Children completed investigation for TB infection
(tuberculin skin test) and TB disease (symptom evaluation, chest radiograph, bacteriology) in both studies using standard
approaches. The impact of MDR-TB exposure on each covariate of TB infection and TB disease was assessed using
univariable and multivariable logistic regression.
Results: Of 538 children included, 312 had DS-TB and 226 had MDR-TB exposure. 107 children with DS-TB exposure had
TB infection (34.3%) vs. 101 (44.7%) of children with MDR-TB exposure (adjusted Odds Ratio [aOR]: 2.05; 95% confidence
interval [CI]: 1.34–3.12). A total of 15 (6.6%) MDR-TB vs. 27 (8.7%) DS-TB child contacts had TB disease at enrolment (aOR: 0.
43; 95% CI: 0.19–0.97).
Conclusions: Our results suggest a higher risk of TB infection in child contacts with household MDR-TB vs. DS-TB
exposure, but a lower risk of TB disease. Although potentially affected by residual confounding or selection bias, our
results are consistent with the hypothesis of impaired virulence in MDR-TB strains in this setting.
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In 1953, Middlebrook and Cohn demonstrated that myco-
bacteria resistant to isoniazid were less able to cause disease
in guinea pigs than susceptible organisms [1]. More recently,
in the laboratory, rifampicin-resistant organisms have been
demonstrated to be less able to grow in competition assays
than rifampicin-susceptible organisms [2]. However, with
time, the rifampicin-resistant organisms frequently develop
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develop in a clinical context. This situation is complicated
by differences in virulence between different mycobacterial
strains [4, 5] and an association between certain strains and
drug resistance [6, 7].
It is important to define “fitness” from the organism’s
perspective. To reproduce, Mycobacterium tuberculosis
must first be transmitted to a new host (requiring ‘in-
fectivity’) and then cause disease (requiring ‘virulence’).
The probability of causing tuberculosis (TB) infection in
a contact is a function of the infectivity of the organism,
the infectiousness of the source case (bacillary load), the
duration and intensity of the exposure, and the innate
and adaptive immune response of the exposed contact.
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courses of inadequate treatment may lead to progression
of disease severity and more infectious TB, leading to
prolonged periods of exposure in their contacts. The
probability of causing disease once infected is however a
function of the virulence of the organism and is also
affected by host factors including age, immunity, the use
of effective preventive therapy and other factors.
The issue of infectivity and virulence in the context of
drug-resistant (DR)-TB is important as it is central to
our understanding of the evolution of the DR-TB epi-
demic. Mathematical models that assume a fixed fitness
cost predict that DR-TB will remain a localised problem
and will not evolve into a global epidemic [8]. Models
that include heterogeneity in levels of fitness, created by
compensatory mutations, however, suggest that the DR-
TB epidemic will evolve globally unless specific interven-
tions are employed [9]. We evaluated the impact of drug
resistance on the infectivity and virulence of M. tubercu-
losis by determining the risk of TB infection and TB dis-
ease in young child household contacts of DR-TB and
drug-susceptible (DS)-TB source cases soon after the
diagnosis of TB in the identified source case.
Methods
Data sources
We completed secondary analysis from two complemen-
tary observational cohort household contact investiga-
tion studies conducted in parallel in Cape Town,
Western Cape, South Africa. The study population con-
sisted of children of black African (mainly Xhosa ethni-
city) and mixed race (an ethnic group of mixed ancestry)
from urban communities in the Cape Town metropol-
itan area. The overall TB notification rate in the Cape
metropolitan area was 928/100,000 in 2011 (Western
Cape Department of Health). Bacillus Calmette-Guérin
(BCG) vaccine was routinely given at birth.
Data were obtained from children with household TB
exposure to a case of infectious pulmonary DS-TB or
MDR-TB (defined as disease caused by M. tuberculosis
resistant to isoniazid and rifampicin), who were routinely
diagnosed and treated at the local TB facility, and were
enrolled in two contact investigation studies imple-
mented between August 2008 and June 2011. All source
cases were sputum culture-positive for M. tuberculosis
and had DST completed. Source cases were classified as
sputum acid-fast bacilli smear-positive (smear-positive)
or smear-negative. Primary study findings of the two co-
hort studies have been previously reported [10, 11]. Chil-
dren were eligible for inclusion in this analysis if they
were younger than five years old and had an available
Mantoux tuberculin skin test (TST) result.
Children with DS-TB exposure were recruited through
household contact investigation in three high-burden TBcommunities (Ravensmead, Uitsig and Khayelitsha),
while children with MDR-TB exposure were enrolled
through household contact investigations from Khayelit-
sha, and from a paediatric outpatient clinic at the
provincial Tygerberg Hospital, which supports clinical
services to children exposed to MDR-TB from commu-
nities in the larger metropolitan Cape Town area. Chil-
dren were recruited by different clinical teams from the
same research group. All children were evaluated using
standardised techniques and data were captured using
standardised forms and tools. All adult TB source cases
were identified by local TB clinics and had confirmed
pulmonary TB. Routine bacteriological investigation
on sputum including sputum smear microscopy (aura-
mine) using standard World Health Organization
guidelines [12] and genotypic DST were completed as
per local guidelines. Mycobacterial liquid culture was
completed using the MGIT 960 system, Becton Dick-
inson, Sparks, MD, USA and DST completed using
the commercial Line Probe Assay (LPA; GenoType®
MTBDRplus; Hain Lifescience, Nehren, Germany).
MDR-TB index cases had resistance to both rifampi-
cin and isoniazid detected on LPA. DS-TB cases en-
rolled had been initiated on TB treatment during the
preceding 3 months, and MDR-TB cases during the
preceding 6 months.
Investigations
Children were classified as being a household contact
based on a definition of household which was developed
and validated in the study setting, namely all dwellings
on the same plot of land that share the same residential
address [13]. All children were investigated for TB infec-
tion and TB disease status in the same manner using
standard protocols. TST was completed by injecting two
tuberculin units intradermally (purified protein derivate
RT23, Statens Serum Institute), read at 48–72 h. TSTs
were placed and read by trained research nurses using
the caliper method. A diameter of ≥10 mm was consid-
ered positive in HIV-negative and ≥5 mm in HIV-
positive children. All children with negative or unknown
HIV status were tested for HIV using the Determine™
HIV-1/2 (Abbott Laboratories, Il, USA). Positive or inde-
terminate HIV rapid tests were confirmed with ELISA
(children >18 months) or DNA polymerase chain reac-
tion (PCR; children <18 months).
Standard clinical examination and chest radiography
(anteroposterior and lateral) was completed in all chil-
dren and gastric aspirates completed as clinically indi-
cated (i.e., in the presence of symptoms suggestive of TB
or suggestive chest radiograph findings). TB microbio-
logical investigation was completed as described for
adult source cases. TB disease in child contacts was
defined as confirmed, probable or suspected, using a
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investigation studies [14].
Clinical care
Children diagnosed with DS- or MDR-TB disease were
treated based on national and international guidelines.
Following exclusion of TB disease, children exposed to
MDR-TB were prescribed a preventive therapy regimen
based on a local standard of care regimen, consisting of
ofloxacin, high-dose isoniazid and ethambutol [15]. Chil-
dren exposed to DS-TB were referred to routine health
services for a standard 6 month course of daily isoniazid.
Data collection
For children enrolled, information was collected from
parents and caregivers on multiple clinical and social
factors. Relevant TB medical history was collected from
adult TB source cases and verified from clinic-based TB
treatment registers and medical records. Data were also
collected on household socio-economic status using an
asset-based questionnaire from which an index variable
was derived from data on reported household assets,
with one point awarded for each of a radio, a television,
a refrigerator, a cell phone, a phone landline, or a bi-
cycle, and five points for a car, for a total of 11 possible
points. This was subsequently categorised into “low” or
“high” based on the observed median value.
Statistical analysis
The datasets from the two studies were combined and
relevant variables extracted. Exposures of interest for
each outcome were identified prior to analysis using Di-
rected Acyclic Graphs, a method for identifying potential
confounders and effect modifiers a priori. VariablesFig. 1 Representation of statistical analysis and classification of cases into Tidentified as potentially relevant for the child’s infection
status included ethnicity, age, gender, the MDR-TB sta-
tus of the adult, whether the child and the adult slept in
the same room, the child’s BCG vaccination status (scar
and/or documentation on immunization card), child’s
previous TB treatment history, reported household to-
bacco smoking exposure, underweight (as measured by
weight for age z-score), HIV status, and household so-
cioeconomic status. The smear status of the adult was
also identified as a likely determinant of infection status
in the child. However as smear status is largely a result
of MDR-TB status, this variable was excluded from the
multivariable model for infection. Variables identified as
relevant to the child’s disease status among the subset of
children with TB infection included age, HIV status,
BCG vaccination status, underweight, household tobacco
smoke exposure, and the MDR-TB status of the adult.
Children were categorised as being TB exposed unin-
fected (no TB disease and negative TST), TB infected
(no TB disease and positive TST) or TB diseased. For
the category of TB disease we included children who
had confirmed, probable and suspected TB disease. The
two main outcomes of interest were TB infection and
TB disease. Analysis of risk factors for TB infection
compared TB exposed uninfected children to those with
TB infection and TB disease, using the variables
described above. Analysis of risk factors for TB disease
was restricted to children with either TB infection or TB
disease (Fig. 1). The statistical significance of baseline
differences in relevant covariates according to whether
the child was exposed to DS-TB vs. MDR-TB, and to
outcome status, were assessed using chi-squared tests.
The impact of MDR-TB exposure and of each covariate
on both TB infection and TB disease status was assessedB exposed uninfected, TB infection and TB disease groups
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Analyses were performed in Stata 13 (StataCorp, Texas,
USA). Due to the small number of children with HIV, we
performed sensitivity analyses restricted to HIV-negative
children to assess whether small cell sizes substantially
affected results. We also performed a sensitivity analysis
to ascertain whether household-level clustering had any
material impact on the results, as some children shared
the same adult contact.
Results
The sample analysed consisted of 316 (58.0%) children
from the DS-TB cohort and 229 (42.0%) from the MDR-
TB cohort studies (total n = 545). Children had a
median age of 2 years 7 months (inter-quartile range
(IQR) 15 months, 3 years 8 months), and were predom-
inantly of mixed race ethnicity (n = 388, 71.2%). Most
other children were of black African ethnicity (n = 153,
28.0%); one child was European, two Indian, and one
“other”. Nine children (1.7%) were HIV-positive. MDR-
TB child contacts differed from DS-TB contactsTable 1 Baseline characteristics in children with household multidru
exposure
Risk factors and clinical states DS-T
Child factors
< 1 year 48 (1
1 year 66 (2
2 years 71 (2
3 years 73 (2
4 years 58 (1
Male 162 (
Black African (vs. mixed race) 52 (1
HIV-positive 1 (0.3
BCG scar/vaccination documented 310 (
Previous tuberculosis treatment 8 (2.5
Weight for age (z-score) < −2 32 (1
Sleeps in same room as TB source case 79 (2
Sleeps in same bed as TB source case 20 (6
Adult source case /household factors
Source case sputum acid-fast bacilli smear-positive 181 (
Household tobacco smoke exposure 245 (
Mean socioeconomic index (x/11), n (standard deviation) 4.0 (2
Clinical states
Exposure no infection 205 (
Infection no disease 80 (2
Disease 27 (8
p < 0.011*; p < 0.001**
MDR-TB Mycobacterium tuberculosis resistant to rifampicin and isoniazid (defined by
DS-TB Mycobacterium tuberculosis susceptible to rifampicin and isoniazid (defined bregarding several relevant covariates (Table 1): they were
more likely to be of black ethnicity (44.1% vs. 16.5%;
p < 0.001), more likely to be HIV-positive (3.7% vs. 0.3%;
p < 0.01), were less likely to have a BCG scar or docu-
mented BCG vaccination (81.2% vs. 98.1%; p < 0.001),
were more likely to have had previous TB treatment
(9.2% vs. 2.5%; p < 0.01), and were less likely to have
been exposed to household tobacco smoke (63.3% vs.
80.4%; p < 0.001).
TST results were missing in four children in the DS-
TB group and in six children in the MDR-TB group.
These were excluded from analyses unless they had TB
disease (used as a proxy for TB infection). Three chil-
dren in the MDR-TB-exposed group were diagnosed
with TB disease but did not have a TST result available,
and were included. Therefore 538 of 545 children had
outcome data available. Among child contacts of DS-TB
source cases, 34.3% of children (107/312) had evidence
of TB infection compared to 44.7% of contacts of MDR-
TB source cases (101/226). Twenty seven of 312 child
DS-TB contacts (8.7%) had TB disease (seven wereg-resistant tuberculosis and drug-susceptible tuberculosis
B exposure (n = 316) N (%) MDR-TB exposure (n = 229) N (%)
5.2) 50 (21.8)
0.9) 41 (17.9)
2.5) 44 (19.2)
3.1) 56 (24.5)
8.4) 38 (16.6)
51.3) 119 (52.2)
6.5) 101 (44.1)**
) 8 (3.7)*
98.1) 181 (81.2)**
) 21 (9.2)*
0.1) 23 (10.1)
5.3) 34 (15.0)**
.4) 57 (25.2)**
62.9) 180 (80.0)**
80.4) 145 (63.3)**
.6) 4.1 (2.5)
65.7) 125 (61.3)
5.6) 86 (38.1)*
.7) 15 (6.6)
line probe assay)
y line probe assay)
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(6.6%) who had disease (three were confirmed).
In univariable analysis children with TB infection
were more likely to be older than two years, more
likely to have had previous TB treatment, and more
likely to sleep in the same bed as the adult TB source
case compared to TB exposed uninfected children
(Table 2; Fig. 2). Children with TB disease were more
likely to be younger than two years, less likely to be
of black African ethnicity, more likely to be underweight-
for-age, and more likely to have household tobacco smoke
exposure (Table 3).
In the multivariable model for TB infection, age older
than two years was associated with higher odds of hav-
ing TB infection (Table 2), as was exposure to a source
case with MDR-TB (adjusted odds ratio [aOR]: 2.05; 95%
confidence interval [CI]: 1.34–3.12). Children of black
African ethnicity were less likely to be TB-infected com-
pared to children of mixed race or other ethnicities.Table 2 Characteristics associated with tuberculosis infection status
multidrug-resistant tuberculosis
Total
Child factors
Age < 2 years 203
Age ≥ 2 years 335
Female 259
Male 278
Mixed race / other ethnicity 390
Black African ethnicity 148
HIV-negative 518
HIV-positive 9
No BCG scar /no vaccination documented 45
BCG scar/vaccination documented 487
No prior tuberculosis treatment (disease) 509
Prior tuberculosis treatment (disease) 29
Weight for age (z-score) ≥ −2 482
Weight for age (z-score) < −2 54
Sleeps in different room to TB source case 348
Sleeps in same room as TB source case 113
Sleeps in same bed as TB source case 77
Adult source case/household factors
DS-TB source case 312
MDR-TB source case 226
No household tobacco smoke exposure 144
Household tobacco smoke exposure 394
Socioeconomic index ≥ 5/11 419
Socioeconomic index <5/11 119
MDR-TB Mycobacterium tuberculosis resistant to rifampicin and isoniazid (defined by
DS-TB Mycobacterium tuberculosis susceptible to rifampicin and isoniazid (defined bIn the multivariable model for TB disease, age older
than two years was protective against TB disease (Table
3). Being exposed to MDR-TB was associated with a
lower odds of TB disease (aOR: 0.43; 95%CI: 0.19–0.97).
HIV-positive children had markedly higher odds of hav-
ing TB disease compared to HIV-negative children.
Restricting the analysis to HIV-negative children did not
substantially affect the results for TB disease. Although
the precision of the estimates for HIV was low, HIV in-
fection was retained in the final model as HIV status was
a key determinant of TB disease. The sensitivity analysis
accounting for clustering did not materially change the
results for either TB infection or TB disease.
Discussion
In this study we present a cross-sectional analysis com-
paring baseline data from two large cohorts of young
children with documented household exposure to infec-
tious TB, one group exposed to DS-TB and the other toin child contacts of drug-susceptible tuberculosis and
Infected N (%) OR (95%CI) AOR (95% CI)
64 (31.5%) ref ref
144 (43%) 1.64 (1.13, 2.36) 1.61 (1.09, 2.37)
96 (37.1%) ref ref
112 (40.3%) 1.15 (0.81, 1.62) 1.02 (0.70, 1.47)
161 (41.3%) ref ref
47 (31.8%) 0.66 (0.44, 0.99) 0.54 (0.33, 0.88)
202 (39%) ref ref
3 (33.3%) 0.78 (0.19, 3.16) 0.66 (0.15, 2.94)
16 (35.6%) ref ref
191 (39.2%) 1.17 (0.62, 2.21) 1.62 (0.80, 3.29)
189 (37.1%) ref ref
19 (65.5%) 3.22 (1.47, 7.06) 2.36 (1.03, 5.39)
186 (38.6%) ref ref
21 (38.9%) 1.01 (0.57, 1.80) 1.04 (0.56, 1.92)
132 (37.9%) ref ref
40 (35.4%) 0.90 (0.58, 1.40) 0.85 (0.53, 1.36)
36 (46.8%) 1.44 (0.87, 2.36) 1.05 (0.60, 1.82)
107 (34.3%) ref ref
101 (44.7%) 1.55 (1.09, 2.20) 2.05 (1.34, 3.12)
50 (34.7%) ref ref
158 (40.1%) 1.26 (0.85, 1.87) 1.22 (0.76, 1.94)
165 (39.4%) ref ref
43 (36.1%) 0.87 (0.57, 1.33) 0.79 (0.51, 1.25)
line probe assay)
y line probe assay)
Fig. 2 Baseline characteristics stratified by TB exposed uninfected, TB infection and TB disease status
Table 3 Characteristics associated with tuberculosis disease in child contacts of drug-susceptible tuberculosis and multidrug-resistant
tuberculosis, among children with tuberculosis infection
Total Disease N (%) OR (95% CI) AOR (95% CI)
Child factors
Age < 2 years 64 20 (31.3%) ref ref
Age ≥ 2 years 144 22 (15.3%) 0.40 (0.20, 0.80) 0.32 (0.15, 0.71)
HIV negative 202 40 (19.8%) ref ref
HIV positive 3 2 (66.7%) 8.10 (0.72, 91.57) 23.0 (1.11, 477.86)
No BCG scar / no vaccination documented 16 3 (18.8%) ref ref
BCG scar / vaccination documented 191 39 (20.4%) 1.11 (0.30, 4.09) 1.14 (0.21, 6.20)
Weight for age (z-score) ≥ −2 186 34 (18.3%) ref ref
Weight for age (z-score) < −2 21 7 (33.3%) 2.24 (0.84, 5.96) 2.17 (0.72, 6.55)
Adult source case factors
DS-TB 107 27 (25.2%) ref ref
MDR-TB 101 15 (14.9%) 0.52 (0.26, 1.04) 0.43 (0.19, 0.97)
Smear-negative source case 43 4 (9.3%) ref ref
Smear-positive source case 155 35 (22.6%) 2.84 (0.95, 8.51) 4.24 (1.31, 13.78)
MDR-TB Mycobacterium tuberculosis resistant to rifampicin and isoniazid (defined by line probe assay)
DS-TB Mycobacterium tuberculosis susceptible to rifampicin and isoniazid (defined by line probe assay)
Golla et al. BMC Infectious Diseases  (2017) 17:593 Page 6 of 10
Golla et al. BMC Infectious Diseases  (2017) 17:593 Page 7 of 10MDR-TB, from the same study setting and investigated
using standardised protocols. We found that a higher
proportion of children exposed to MDR-TB had
evidence of TB infection when enrolled but that a lower
proportion had TB disease. Children of mixed race
ethnicity were at increased risk of TB infection as were
older children. Children with HIV infection were at an
increased risk of having TB disease, as were younger
children. Overall, our results are consistent with data
from other studies. Systematic reviews of the yield from
household contact investigations demonstrate similar
proportions of child contacts having prevalent TB infec-
tion and TB disease in both DS-TB [16] and MDR-TB
contacts [17].
The relation between age, HIV status and the risk of
TB infection and disease is well established in children
[18, 19]. As children become older there is an increasing
probability of TST positivity due to accumulated age-
related TB exposure [20]. It is also possible that the re-
duced sensitivity of the TST in younger children may
lead to false negatives, with fewer children being diag-
nosed with TB infection. However, we have found lim-
ited evidence for this effect in a large contact
investigation in our setting [10]. False positive TST status
in young children (<2 years of age) due to BCG effect
could have led to more young children being TST posi-
tive, which was not observed in our study. Young age
and HIV infection status are both well recognised risk
factors for progressing to TB disease following M. tuber-
culosis infection, given the developing immune system
and the impact of T-cell immunological suppression, re-
spectively [21]. Our study again highlights the vulner-
ability of these children, who are in most need of early
identification and preventive therapy before they pro-
gress from infection to disease [18, 22].
There was a clear influence of drug resistance on the
risk of TB infection and disease in young children in our
study. While these results could be, to some extent, the
result of residual confounding, they are consistent with
findings from other studies and also with plausible bio-
logical mechanisms. Children exposed to MDR-TB
source cases are likely to have been exposed for pro-
longed periods of time and to more severe (and conse-
quently infectious) TB disease in the source case, due to
diagnostic and treatment delay in adults with MDR-TB
[23]. That fewer children had progressed to TB disease
at screening may reflect different populations and socio-
economic circumstances associated with MDR-TB
households vs. DS-TB households. However, it is
possible that this reduced prevalence of TB disease in
children exposed to MDR-TB reflects reduced virulence
of resistant mycobacteria.
A number of epidemiological studies have observed no
differences in the risk of TB infection and/or diseasebetween contacts exposed to DR-TB and DS-TB. Bar-
rosso and colleagues carried out a case-control study in
Brazil between 1990 and 1999. They evaluated the con-
tacts of 126 patients with MDR-TB and 176 with DS-TB
and found similar numbers of contacts per source case
between the two groups. They also found similar pro-
portions of contacts who went on to develop incident
TB disease [24]. Snider and colleagues compared the risk
of infection in contacts of nearly four hundred DR-TB
cases to the risk in contacts of a similar number of
matched DS-TB cases. This study was carried out in the
USA from 1975 to 1977. The DR-TB cases had disease
caused by strains of M tuberculosis resistant to isoniazid
and/or streptomycin, and household childhood contacts
(<15 years) were evaluated for evidence of TST positiv-
ity. No difference in TST positivity was found between
the two groups of contacts [25]. Teixeira and colleagues
evaluated contacts of MDR-TB and DS-TB for evidence
of TB infection and TB disease. This study was con-
ducted in Brazil between 1994 and 1998. Amongst 157
household contacts of 26 MDR-TB cases there was no
difference in risk of TB infection or prevalent TB dis-
ease, as compared to 251 contacts of 52 DS-TB cases
[26]. In contrast to these studies, Grandjean and col-
leagues recently carried out a study in Peru which dem-
onstrated that adult and child household contacts of
MDR-TB patients were only half as likely to develop in-
cident TB disease compared to contacts of DS-TB [27].
An observational study from India found that contacts
of isoniazid-resistant TB were more likely to have TB in-
fection compared to contacts of DS-TB, but that on
follow-up, both groups had similar rates of incident TB
[28]. A study from Romania demonstrated lower rates of
TB infection and prevalent disease in child household
contacts of patients with isoniazid-resistant TB disease
compared to DS-TB [29]. Our results add to this body of
work and are consistent with some of the previous stud-
ies but are different to others. Differences between stud-
ies may be a result of differing research methodologies.
Although approaches were relatively similar between the
different studies described above, differences in duration
of exposure, and definitions of infection and disease, var-
ied to some degree. Some studies evaluated prevalent
TB disease while others incident disease in those found
to be disease-free at baseline. Differences may be the
result of urban vs. rural settings, the presence of HIV
infection, the degree of poverty, the health systems in
which children were evaluated, or that studies were con-
ducted in different time periods. For paediatric TB, the
likelihood of a confirmed diagnosis is impacted, to some
extent, by how thoroughly a child is investigated. Some
settings may have investigated drug-resistant contacts
more extensively than those exposed to drug-susceptible
source cases. Conversely, due to the toxicity and
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may have been more willing to clinically diagnose chil-
dren with TB disease if exposed to a drug-susceptible
case than than to an MDR-TB case. Finally genetic dif-
ferences between host and pathogen populations may
also have influenced rates of infection and disease. The
relationship between train types, resistance and virulence
is complex and influenced by geography [4–7]. To com-
prehensively address this question, a prospective, multi-
site study could evaluate child contacts of drug-resistant
and drug-susceptible TB source cases, with children in-
vestigated by study teams trained using standardised
methodology in real-time. Ideally, those investigating the
children would be blinded to exposure.
Our study has a number of limitations. First, data ana-
lyses were cross-sectional. We evaluated children at the
first visit following identification of the TB source case,
and this analysis assessed prevalent TB infection and
disease only. For TST, we acknowledge that a small pro-
portion of cases will test negative at initial screening (if
seen very early before immunological memory has been
established) but may subsequently convert their TST.
Second, we acknowledge that TST is an imperfect meas-
ure of TB infection, especially in young and HIV-
positive children, where interferon-gamma release assays
(IGRAs) have improved sensitivity and specificity [10,
30]. We did not consider IGRA results in this analysis,
as they were not available for the MDR-TB cohort. We
also acknowledge that previous TB disease, BCG vaccin-
ation, and non-tuberculous mycobacterial infection may
all have led to a positive TST result. It is also possible
that children may have had undocumented exposure to
other mycobacterial strains (i.e. outside of documented
household exposure); this would however not be ex-
pected to be different between DS- and MDR-TB ex-
posed children aged below five years of age. Third, we
did not report on incident TB during follow-up. Fourth,
the two studies were conducted separately but in paral-
lel. Although separate clinical teams conducted the two
studies, both were conducted by the same centre and re-
search personnel were trained in a standard manner.
Prior to study implementation, we standardised study
practices with consistent training, data collection tools,
TB investigations and case definitions for TB infection
and disease. However, in the DS-TB cohort, children
were recruited if they had been exposed in the preceding
three months to an infectious source case, whereas in
the MDR-TB cohort a six month cut-off was used. If this
had caused selection bias, however, it would have served
to attenuate any negative association between MDR-TB
exposure and TB disease rather than exaggerate it, as
children in the MDR-TB cohort had twice as long to de-
velop TB before the baseline assessment. Nonetheless,
we saw a substantially lower prevalence of diseaseamong the MDR-TB cohort. It is possible that the differ-
ing exposure cut-off may have biased the TB infection
analysis towards an increased effect estimate in the
MDR-TB exposed cohort. There is an additional possi-
bility of bias in the MDR-TB child contacts due to enrol-
ment of some children at hospital, compared to the
community-based recruitment strategy for DS-TB con-
tacts. The recruitment catchment areas, although over-
lapping and drawing patients from similar communities,
were not identical – this is reflected in more black Afri-
can children in the MDR-TB group and also a higher
proportion of children with HIV infection and a lower
proportion with evidence of BCG vaccination. The
prevalence of DR-TB in the catchment areas, however,
are unlikely to be different given the results of previous
DST surveys which showed similar rates of DR-TB be-
tween children from Tygerberg Hospital and surround-
ing communities [31]. A further potential source of bias
was that clinicians were not blinded to the DST pattern
of the source case. Even with the use of standardised
protocols and TB disease definitions, it is possible that
clinicians may have been more willing to make a diagno-
sis of TB disease in children exposed to DS-TB due to
shorter and less toxic treatment.Conclusions
We demonstrate that children exposed to MDR-TB are
more likely to have a positive test of TB infection than
children exposed to DS-TB but are less likely to present
with prevalent TB disease. Although potentially affected
by residual confounding or selection bias, our results are
consistent with the hypothesis of impaired virulence in
MDR-TB strains in this setting.
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